Dexamethasone Inhibits the Growth of B‐Lymphoma Cells by Downregulating <scp>DOT1L</scp>
Overall, our findings indicated that DOT1L may serve as a potential drug target and a promising biomarker of Dex sensitivity when it comes to treating B lymphoma.
Authors
- Fengtian He (ORCID: https://orcid.org/0000-0002-1689-6281)
- Xiancai Rao (ORCID: https://orcid.org/0000-0002-9905-760X)
- Weilong Shang (ORCID: https://orcid.org/0000-0002-0752-5016)
- Huagang Peng (ORCID: https://orcid.org/0009-0003-5828-8764)
- Zhen Hu (ORCID: https://orcid.org/0000-0003-3741-6141)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-9675-5322)
- Yuting Wang (ORCID: https://orcid.org/0000-0002-0219-2590)
- Li Zhang (ORCID: https://orcid.org/0000-0002-9386-8938)
- Yi Yang (ORCID: https://orcid.org/0000-0002-6679-4021)
- Li Tan
Institutions
- Central South University (CN)
- Army Medical University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cnr2.2150
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China